ArticlemedRxiv : the preprint server for health sciences2024

Metformin reduces the risk of poor treatment outcomes among individuals with rifampicin-resistant tuberculosis and type-2 diabetes mellitus.

Argita D Salindri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.